BMY

Stock Market Today, June 18: Pfizer Falls as CFO Transition Tests Confidence in 2026 Outlook

06/18 07:09 pm

3 Dividend Stocks to Hold for the Long Haul

06/16 06:15 am

How Safe is Bristol Myers Squibb's Dividend? Here's My Honest Take.

06/13 06:15 pm

Bristol Myers Squibb Dividend Raise Streak is 18 Years. Here's 1 Number That Says the Streak Will Continue.

06/11 02:02 pm

Takeda AI-Drug Shows Superior Skin Clearance Against Bristol-Myers' Med

06/11 01:12 pm

Nxera Joins OpenFold AI Research Consortium Alongside Leading Global Pharmaceutical and AI Companies to Accelerate AI-enabled Drug Discovery

06/10 02:35 am

Better High-Yield Dividend Stock to Buy: Bristol Myers Squibb or Pfizer?

06/04 02:30 am

Recursion Pharmaceuticals vs. Schrödinger: Which Healthcare Stock Is a Better Buy in 2026?

06/02 05:12 pm

Why Bristol Myers Squibb Stock Isn't Nearly As Cheap As It Looks

06/01 11:15 pm

CRISPR Therapeutics' Secret Weapon That Many Investors Are Overlooking

06/01 12:30 pm

CRISPR Therapeutics vs. Editas Medicine: Which Gene Editing Stock Is a Better Buy in 2026?

05/31 12:11 pm

Globale Daten der ROSETTA Lung-02-Studie: Ermutigende Wirksamkeit für BioNTechs und Bristol Myers Squibbs bispezifischen PD-L1xVEGF-A-Immunmodulator-Kandidat Pumitamig bei nicht-kleinzelligem Lungenkrebs

05/30 02:15 pm

Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial

05/30 02:15 pm

BioNTech to Showcase Progress Across Late-Stage Oncology Pipeline at the 2026 ASCO Annual Meeting

05/22 05:00 am

BioNTech präsentiert auf der ASCO-Jahrestagung 2026 Fortschritte aus Pipelineprogrammen in der späten klinischen Entwicklung

05/22 05:00 am

The Most Undervalued Healthcare Stock in the S&P 500 Right Now

05/21 07:05 am

Anthropic And OpenAI--Building Different Competitive Advantages

05/20 02:18 pm

Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug Discovery

05/20 01:09 pm

Tempus AI, Bristol Myers Squibb Expand AI-Driven Clinical Trial Efforts

05/14 02:23 pm

Global Colorectal Cancer Diagnostics and Therapeutics Market Anticipates Impressive Growth Trajectory at a CAGR of ~9% by 2034 | DelveInsight

05/13 01:00 pm

AstraZeneca's Rare Disease Drug Shows Reduced Dependence On Calcium Supplements

05/12 10:03 am

Wall Street's Cardiac Bet: Where Diagnostics Meet the Money

05/12 08:30 am

Is Bristol Myers Squibb Stock Overvalued at Nearly $60? A Reality Check for Value Investors.

05/11 09:15 pm

Global Personalized Medicine to Transform Modern Healthcare and Cross USD 1 Trillion by 2034 | DelveInsight

05/11 01:00 pm

Why Bristol Myers Squibb Stock Rocked the Market Today

04/30 04:17 pm

Why Is Bristol-Myers Squibb Stock Trading Higher On Thursday?

04/30 02:12 pm

Rheumatoid Arthritis Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 75+ Leading Players Wheeling the Therapeutics Landscape

04/28 01:00 pm

Stock Market Today, April 27: Organon Shares Surge After Sun Pharma Agrees to Acquire Company in All Cash Deal

04/27 05:34 pm

AI Disruption in Lung Cancer Therapeutics Set to Transform Treatment Paradigms as Billion-Dollar Investments Drive Innovation

04/27 01:36 pm

Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight

04/27 01:00 pm

3 Biotech Stocks That Could Benefit from the Patent Cliff

04/27 11:29 am

Vulvar Cancer Market Global and Regional Analysis Report 2025-2035, Profiles of Merck & Co., Bristol Myers Squibb, and AstraZeneca

04/22 05:59 am

Follicular Lymphoma Clinical Trial Space Intensifies with 45+ Companies in Active Development | DelveInsight

04/21 01:00 pm

Targeted Alpha Therapy Market Landscape Report 2026-2030: Clinical Trials Insights on 30 Drugs - Size, Regulatory Approvals, Proprietary Technologies, Therapeutic Applications

04/21 04:27 am

Oncolytic Virus Immunotherapy Market Landscape Report 2026: A $5 Opportunity by 2031 - Technology Platforms, Approved Therapy Dosage, Price & Clinical Trials Insights

04/21 04:14 am

Alpha Thalassemia (US, EU4, UK, and Japan) Market Insights, Epidemiology, and Forecasts 2022-2025 & 2025-2036

04/13 04:47 am

Which Dividend Pharma Stock Should a Value Investor Choose Today?

04/12 08:28 pm

2 Recession Resistant Dividend Stocks to Buy Now While They're Still Cheap

04/10 06:30 am

7MM Systemic Lupus Erythematosus and Lupus Nephritis Drug Market Analysis & Forecast 2024-2034: Future SLE and LN Players Competition, High Unmet Need for Steroid-sparing Treatments

04/10 04:59 am

Oxford BioTherapeutics Enters Strategic Collaboration with Bristol Myers Squibb to Discover and Develop Next-Generation T-cell Engagers for Solid Tumours

04/09 07:00 am

Interstitial Lung Disease Market to Witness Accelerated Growth at a CAGR of 8.7% During the Forecast Period (2026–2036) Due to the Launch of Emerging Therapies | DelveInsight

04/08 01:00 pm

Trump Imposes 100% Drug Tariffs: 5 Pharma Stocks That Won’t Pay a Dime

04/06 01:20 pm

Bile Duct Cancer Market to Grow by $1.07 Billion During 2026-2030: Key Trends, Investment Opportunities and Competitive Strategies Analyzed

03/30 06:00 am

Esophageal Cancer Market to Grow from $1.65 Billion in 2026 to $2.37 Billion by 2030: Pfizer, Roche, Merck & Co. Dominate

03/30 05:00 am

What Is Considered a Good Stock Dividend? 2 Healthcare Stocks Fit the Bill.

03/24 07:06 am

Should You Buy Bristol Myers Squibb Stock for Its 4.4%-Yielding Dividend?

03/23 04:30 pm

Bristol Myers Secures FDA Nod For Opdivo Plus Chemo For Untreated Hodgkin Lymphoma

03/20 01:57 pm

CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants

03/17 10:46 pm

The $3B Biotech With Two Shots On Goal

03/17 07:07 am

1 ETF That Could Turn $100 Per Month Into $67,380

03/15 05:05 am